01:38 PM EDT, 09/02/2025 (MT Newswires) -- Outlook Therapeutics ( OTLK ) said Tuesday it submitted a Type A meeting request to the US Food and Drug Administration to discuss a complete response letter for a biologics license application resubmission for ONS-5010, an investigational treatment for wet macular degeneration. The company said it has requested a meeting as it seeks...

Merck & Co. Inc. ( MRK ) on Tuesday shared topline results from the Phase 3 CORALreef Lipids trial evaluating the safety and efficacy of enlicitide decanoate for hypercholesterolemia on a moderate or high intensity statin (or with documented statin intolerance). Hypercholesterolemia, a type of hyperlipidemia, is a disorder in which there are elevated LDL cholesterol levels in the blood....

01:35 PM EDT, 09/02/2025 (MT Newswires) -- Nauticus Robotics ( KITT ) said Tuesday it will implement a one-for-9 reverse stock split of its common stock effective Friday, following approval by its board and stockholders. The split-adjusted shares will begin trading on the Nasdaq Capital Market on Friday and is intended to increase its share price to comply with the...

01:31 PM EDT, 09/02/2025 (MT Newswires) -- Nukkleus ( NUKK ) said Tuesday it entered into an agreement to acquire Tiltan Software Engineering for $14 million to boost its aerospace and defense portfolio. The Israel-based developer of AI-driven defense simulation platforms will be acquired through a mix of cash and shares to be paid over six months from deal close....